Cephalon Inc Coverage in NH Opioid Settlement
Trusted by teams at
Description
Cephalon, Inc. is included among companies released in the New Hampshire opioid settlement, as part of Allergan’s national multi-year payment and litigation release plan.
Contract Details
Contract Amount
See Allergan Public Global Opioid Settlement Agreement (up to $2,372,972,184.12 national aggregate). NH-specific financial detail not included here.
Vendor
CEPHALON INC
Agency
New Hampshire AG | (Domestic Violence Fatality Review Committee), NH
Contract Type
OTHER
Document Date
September 12, 2023
Contract Term
Annual payments beginning 2023 through 2029, scheduled July 15 each year
Renewal Date
2029-07-15
Renewal Info
No renewal; only amendable with consensus and judicial approval.
More from CEPHALON INC
Issuing Agency
State
Concord, NH
More from New Hampshire AG | (Domestic Violence Fatality Review Committee)
New Hampshire Victim Services Funding RFP SFY27VS01 March 2026
State of New Hampshire v. Publicis Health, LLC Assurance of Discontinuance Feb 2024
State of New Hampshire v. Allergan Limited et al. Consent Judgment Sept 2023
Merrimack Superior Court Consent Judgment and Dismissal Teva Global Opioid Settlement 2023-09-12
Merrimack Superior Court Consent Judgment and Dismissal Teva Global Opioid Settlement 2023-09-12
Get alerts on contract renewals, new awards, and vendor activity.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.